[lu-177]-pnt2002,abiraterone,enzalutamide
astellas,janssen,pfizer,point biopharma
['crpc', 'splash', '$pnt', 'point bio', 'pointbiopharma']
$pnt 8-k point biopharma global (12 sep, 7:54am) point biopharma provides updated efficacy and safety data from the lead-in cohort of the phase 3 splash trial in mcrpc at esmo congress 2022 #pnt #8k #pointbiopharmaglobal #news
Feed of new SEC filings and other useful information for stock market investors.